We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$4.21M
Cap. Flow
-$36.2M
Cap. Flow %
-3.4%
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115

Top Sells

Rank Stock Value
1
OCSL icon
Oaktree Specialty Lending
OCSL
+$12.7M
2
NVDA icon
NVIDIA
NVDA
+$6.29M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.66M
4
AAPL icon
Apple
AAPL
+$3.19M
5
AVGO icon
Broadcom
AVGO
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 12.25%
3 Healthcare 6.29%
4 Communication Services 4.39%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
151
SPDR Gold Trust
GLD
$141B
$765K 0.07%
3,558
+489
+16% +$106K
VBK icon
152
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
$762K 0.07%
3,045
-1
-0% -$249
AMGN icon
153
Amgen
AMGN
$222B
$753K 0.07%
2,409
+463
+24% +$136K
GS icon
154
Goldman Sachs
GS
$303B
$750K 0.07%
1,658
+528
+47% +$232K
CARR icon
155
Carrier Global
CARR
$52.8B
$745K 0.07%
11,810
+236
+2% +$14.5K
AMT icon
156
American Tower
AMT
$80.4B
$742K 0.07%
3,817
+313
+9% +$58.5K
T icon
157
AT&T
T
$163B
$736K 0.07%
38,502
-3,899
-9% -$67.8K
MPC icon
158
Marathon Petroleum
MPC
$83.7B
$732K 0.07%
4,217
+439
+12% +$81.6K
COF icon
159
Capital One
COF
$134B
$728K 0.07%
5,260
+446
+9% +$62.6K
TT icon
160
Trane Technologies
TT
$106B
$718K 0.07%
2,182
-153
-7% -$48.7K
CI icon
161
Cigna
CI
$74.6B
$713K 0.07%
2,157
+35
+2% +$12.1K
ISRG icon
162
Intuitive Surgical
ISRG
$134B
$707K 0.07%
1,590
+142
+10% +$56.6K
BX icon
163
Blackstone
BX
$110B
$703K 0.07%
5,678
+1,212
+27% +$149K
NSC icon
164
Norfolk Southern
NSC
$75.1B
$702K 0.07%
3,269
-972
-23% -$226K
MCK icon
165
McKesson
MCK
$101B
$695K 0.07%
1,190
+57
+5% +$31.7K
CB icon
166
Chubb
CB
$135B
$688K 0.06%
2,699
+125
+5% +$32.1K
XLI icon
167
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$682K 0.06%
5,595
-115
-2% -$14.2K
PH icon
168
Parker-Hannifin
PH
$135B
$680K 0.06%
1,344
-2
-0.1% -$1.07K
CDNS icon
169
Cadence Design Systems
CDNS
$93.4B
$676K 0.06%
2,197
+88
+4% +$26.1K
AZN icon
170
AstraZeneca
AZN
$250B
$669K 0.06%
4,291
+288
+7% +$43.3K
COP icon
171
ConocoPhillips
COP
$141B
$654K 0.06%
5,721
+165
+3% +$20K
HLT icon
172
Hilton Worldwide
HLT
$71.5B
$647K 0.06%
2,964
+77
+3% +$15.8K
MDT icon
173
Medtronic
MDT
$112B
$646K 0.06%
8,209
-197
-2% -$16.1K
DTM icon
174
DT Midstream
DTM
$13.4B
$643K 0.06%
9,046
+8,551
+1,727% +$561K
AXP icon
175
American Express
AXP
$230B
$641K 0.06%
2,768
+164
+6% +$38K

Similar funds

Lindbrook Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.

  • Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
  • Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
  • Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
  • Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
  • Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
  • Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.